University of Alberta Diabetes Institute Encouraged by Preliminary Results of Testing of ProtoKinetix Licensed AAGP™ Molecule in Islet Cell Transplantation
Business News
ST. MARYS, W. Va.--(BUSINESS WIRE)--University of Alberta Diabetes Institute Encouraged by Preliminary Results of Testing of ProtoKinetix Licensed AAGP™ Molecule in Islet Cell Transplantation
protokinetix-logo.jpg
Read more
< Prev
Next >